PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 36 filers reported holding PLURISTEM THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $45,000 | +18.4% | 29,516 | 0.0% | 0.00% | – |
Q2 2017 | $38,000 | +11.8% | 29,516 | +7.3% | 0.00% | – |
Q1 2017 | $34,000 | -17.1% | 27,516 | -3.5% | 0.00% | – |
Q4 2016 | $41,000 | +5.1% | 28,516 | +16.3% | 0.00% | – |
Q3 2016 | $39,000 | +25.8% | 24,516 | +4.3% | 0.00% | – |
Q2 2016 | $31,000 | -18.4% | 23,516 | 0.0% | 0.00% | – |
Q1 2016 | $38,000 | +40.7% | 23,516 | 0.0% | 0.00% | – |
Q4 2015 | $27,000 | -37.2% | 23,516 | -1.3% | 0.00% | – |
Q3 2015 | $43,000 | -17.3% | 23,816 | +14.5% | 0.00% | -100.0% |
Q2 2015 | $52,000 | -1.9% | 20,800 | +10.6% | 0.00% | 0.0% |
Q1 2015 | $53,000 | +29.3% | 18,800 | +14.6% | 0.00% | – |
Q4 2014 | $41,000 | +7.9% | 16,400 | +22.4% | 0.00% | – |
Q3 2014 | $38,000 | -9.5% | 13,400 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $42,000 | -16.0% | 13,400 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $50,000 | +28.2% | 13,400 | +20.7% | 0.00% | 0.0% |
Q4 2013 | $39,000 | +8.3% | 11,100 | +4.7% | 0.00% | 0.0% |
Q3 2013 | $36,000 | +16.1% | 10,600 | +6.0% | 0.00% | 0.0% |
Q2 2013 | $31,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Verity Asset Management, Inc. | 85,378 | $301,000 | 0.33% |
Tower Research Capital LLC (TRC) | 54,690 | $193,000 | 0.03% |
Psagot Value Holdings Ltd. | 54,348 | $191,000 | 0.01% |
OPPENHEIMER & CO INC | 36,450 | $128,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 2,900 | $10,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 34,571 | $121,000 | 0.00% |
Commonwealth Equity Services, Inc | 11,100 | $39,000 | 0.00% |
GROUP ONE TRADING, L.P. | 18,844 | $66,000 | 0.00% |
CITIGROUP INC | 737 | $3,000 | 0.00% |
VAN ECK ASSOCIATES CORP | 21,179 | $75,000 | 0.00% |